Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Milkhaus receives patent protection for DNA treatment of respiratory disorders

March 13, 1998

Interim safety data reported for Procysteine

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

First launch for Synthelabo antihistamine

March 11, 1998

Clinical syndromes associated with zafirlukast therapy in patients with asthma

March 10, 1998

Yamanouchi engages in NK antagonist research

March 6, 1998

U.K. market introduction for Singulair

March 5, 1998

Distribution and marketing of terfenadine-containing products discontinued in U.S.

March 4, 1998

FDA okays labeling change for Pulmozyme

March 3, 1998

Neuropeptide Y Y2 agonists prepared at Peptech/CRC

March 3, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...